March 18, 2021
ARLINGTON, Va. — Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., released the following statement.
“We congratulate Xavier Becerra on his confirmation as the next Secretary of Health and Human Services (HHS). HDA and the nation’s healthcare distributors look forward to working closely with HHS under Secretary Becerra's leadership to address pressing healthcare issues.
“While our country faces many challenges, none are more urgent than the ongoing COVID-19 public health crisis. At this pivotal moment, HDA and our distributor members are committed to partnering with Secretary Becerra to implement the Biden administration’s overall COVID-19 pandemic response, especially as the country’s historic vaccination campaign ramps up. Every day, distributors connect 1,400 manufacturers to more than 180,000 providers. Through our members’ logistics expertise, the industry helps deliver COVID-19 vaccines, treatments and PPE while fulfilling the daily healthcare needs of all Americans.
“Distributors create between $33–$53 billion in savings to the U.S. healthcare ecosystem annually. As Secretary Becerra and HHS focus on the COVID-19 response — and move forward to ensure the access and affordability of healthcare for all Americans — the distribution industry stands ready to collaborate with public- and private-sector partners to promote the safe and reliable distribution of lifesaving medicines, healthcare products and medical supplies to communities across the country.”
The Healthcare Distribution Alliance (HDA) represents primary pharmaceutical distributors — the vital link between the nation’s pharmaceutical manufacturers and pharmacies, hospitals, long-term care facilities, clinics and others nationwide. Since 1876, HDA has helped members navigate regulations and innovations to get the right medicines to the right patients at the right time, safely and efficiently. The HDA Research Foundation, HDA’s non-profit charitable foundation, serves the healthcare industry by providing research and education focused on priority healthcare supply chain issues.